The goal of the project is to understand the function of the S14 protein, which bears no similarity to other sequenced proteins and has not been purified. The S14 gene is expressed only in tissues with high rates of fatty acid formation, including liver, fat and mammary gland. Levels of mRNA S14 are rapidly regulated by stimuli which govern the rate of fat synthesis in these tissues, including thyroid hormone, glucagon, glucocorticoids, dietary carbohydrate, and circadian factors. In each case, levels of the mRNA change concordantly with the effects of these stimuli on fat synthesis in vivo. We have extended our knowledge to the level of the protein itself by raising antisera to synthetic peptides corresponding to portions of the predicted S14 protein amino acid sequence. The antisera allowed localization of the protein to cytosol, elucidation of its electrophoretic characteristics, and the observation that its levels are regulated in accordance with those of mRNA S14. We have recently used the antisera to identify the S14 protein in an adipogenic cell line. We now propose to exploit the antisera to probe for the function of this novel protein, which we believe may be of general importance in the regulation of fat metabolism. This will be accomplished by assessing the effects of removal of the protein from in vitro lipogenic systems, and of adding purified S14 protein to such systems. Binding of lipids to purified S14 protein will also be tested. Purification will be by immunoaffinity chromatography. As a complimentary approach, we propose to introduce regulable S14 genes into lipid-synthesizing cultured cells to determine the effects of expression and deletion of the protein on fat metabolism in living cells. Antisera will be used to quantitate the protein in these experiments. These studies should enhance our understanding of this novel protein and provide a means of determining its precise biological function. Such knowledge may ultimately be applicable to the regulation of lipid metabolism in diabetes mellitus and obesity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043142-04
Application #
3244469
Study Section
Metabolism Study Section (MET)
Project Start
1990-08-01
Project End
1994-03-31
Budget Start
1992-07-01
Budget End
1994-03-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Moncur, J T; Park, J P; Memoli, V A et al. (1998) The ""Spot 14"" gene resides on the telomeric end of the 11q13 amplicon and is expressed in lipogenic breast cancers: implications for control of tumor metabolism. Proc Natl Acad Sci U S A 95:6989-94
Cunningham, B A; Moncur, J T; Huntington, J T et al. (1998) ""Spot 14"" protein: a metabolic integrator in normal and neoplastic cells. Thyroid 8:815-25
Brown, S B; Maloney, M; Kinlaw, W B (1997) ""Spot 14"" protein functions at the pretranslational level in the regulation of hepatic metabolism by thyroid hormone and glucose. J Biol Chem 272:2163-6
Moncur, J T; Park, J P; Maloney, M et al. (1997) Assignment of the ""spot 14"" gene (THRSP) to human chromosome band 11q13.5 by in situ hybridization. Cytogenet Cell Genet 78:131-2
Cunningham, B A; Maloney, M; Kinlaw, W B (1997) Spot 14 protein-protein interactions: evidence for both homo- and heterodimer formation in vivo. Endocrinology 138:5184-8
Kinlaw, W B; Church, J L; Harmon, J et al. (1995) Direct evidence for a role of the ""spot 14"" protein in the regulation of lipid synthesis. J Biol Chem 270:16615-8
DePalo, D; Kinlaw, W B; Zhao, C et al. (1994) Effect of selenium deficiency on type I 5'-deiodinase. J Biol Chem 269:16223-8
Kinlaw, W B; Tron, P; Witters, L A (1993) Thyroid hormone and dietary carbohydrate induce different hepatic zonation of both ""spot 14"" and acetyl-coenzyme-A carboxylase: a novel mechanism of coregulation. Endocrinology 133:645-50